Kala Pharmaceuticals completes Enrollment of STRIDE 3 Trial for EYSUVIS™ for Dry Eye Disease Medical Dialogues Bureau19 Jan 2020 10:45 AM ISTWatertown: Kala Pharmaceuticals, Inc. (Kala), a biopharmaceutical company focused on the development and commercialization of therapeutics using its...
JnJ Collaborates with The MTV Staying Alive Foundation to Launch health campaigns for Indian Youth Medical Dialogues Bureau19 Jan 2020 10:00 AM ISTMumbai: Johnson & Johnson Services Inc. has announced its collaboration with the internationally acclaimed social change organization The MTV...
CIMZIA now approved in Canada for the Treatment of Non-Radiographic Axial Spondyloarthritis Medical Dialogues Bureau19 Jan 2020 9:45 AM ISTOakville: UCB Canada Inc. announced that Health Canada has approved CIMZIA® (certolizumab pegol) for the treatment of adults with severe active...
German drug assessment body not convinced by Bayer's cancer drug Vitrakvi Medical Dialogues Bureau19 Jan 2020 9:30 AM ISTFrankfurt: Germany's drug assessment body said that data provided by Bayer on its precision cancer drug Vitrakvi did not provide clear enough evidence...
Piramal Divests its Healthcare analytics Business for 950 Million USD Medical Dialogues Bureau18 Jan 2020 3:30 PM ISTIndia: Piramal Enterprises Limited has announced that PEL DRG Dutch HoldCo BV, a 100% subsidiary of PEL and the holding company for Decision Resources...
Johnson & Johnson Risperdal Lawsuit: US Court Slashes USD 8 Billion Verdict Medical Dialogues Bureau18 Jan 2020 12:17 PM ISTNew York: A Pennsylvania court on Friday slashed a USD 8 billion ruling against US pharmaceutical giant Johnson & Johnson, imposed by a jury...
Novo Nordisk's Ozempic® gets USFDA for CV risk reduction in people with type 2 diabetes and established CVD Medical Dialogues Bureau18 Jan 2020 10:36 AM ISTDenmark: Novo Nordisk has announced that the US Food and Drug Administration (FDA) has approved a label expansion based on a supplemental New...
Wockhardt gets DCGI nod for 2 new antibiotics Medical Dialogues Bureau17 Jan 2020 1:57 PM IST 'DCGI has approved Wockhardts 2 new antibiotics, EMROK (IV) and EMROK O (Oral), for acute bacterial skin and skin structure Infections including...
Group B Streptococcus: Hilleman Labs announces to make affordable vaccine Medical Dialogues Bureau17 Jan 2020 1:27 PM ISTNew Delhi:: In a bid to strengthen its vaccine portfolio and expand into areas of unmet need, Hilleman Laboratories, a global research and development...
Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020: CFO Medical Dialogues Bureau17 Jan 2020 12:45 PM ISTSan Francisco: Eli Lilly and Co aim to announce roughly one $1 billion (765 million pounds) to $5 billion (3.8 billion pounds) deal every quarter in...
Govt may impose anti-dumping duty on pharma chemical from China, Saudi Arabia Medical Dialogues Bureau17 Jan 2020 12:00 PM ISTNew Delhi: The government may impose anti-dumping duty on a chemical used in pharma and pesticide industries from China and Saudi Arabia with a view...
Amgen CEO expects 25% of growth to come from Asia in next decade MD bureau16 Jan 2020 1:28 PM ISTSAN FRANCISCO: Biotechnology giant Amgen Inc expects up to a quarter of its growth to come from Asia over the next decade, Chief Executive Officer...
